Short Interest in Talphera, Inc. (NASDAQ:TLPH) Grows By 42.4%

Talphera, Inc. (NASDAQ:TLPH) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 104,100 shares, a growth of 42.4% from the February 28th total of 73,100 shares. Currently, 0.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 75,500 shares, the short-interest ratio is currently 1.4 days.

Talphera Price Performance

Shares of NASDAQ:TLPH traded down $0.08 during mid-day trading on Monday, hitting $0.50. The company had a trading volume of 382,156 shares, compared to its average volume of 77,435. Talphera has a one year low of $0.44 and a one year high of $1.27. The company has a market capitalization of $8.57 million, a PE ratio of -0.73 and a beta of 0.20. The firm has a fifty day moving average price of $0.61 and a 200 day moving average price of $0.71.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. RODMAN&RENSHAW raised shares of Talphera to a “strong-buy” rating in a research note on Tuesday, January 28th. HC Wainwright reiterated a “buy” rating and issued a $6.00 price objective on shares of Talphera in a report on Tuesday, January 21st. Finally, Rodman & Renshaw began coverage on shares of Talphera in a report on Tuesday, January 28th. They set a “buy” rating and a $4.00 target price on the stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.